SlideShare a Scribd company logo
1 of 23
 Norovirus Outbreak in a Long Term Care Facility: A Retrospective Epidemiological Study Gillian Jones MBA MPH, PIDr. Tae LeeDr. Jason Brinkley UMC-IRB # 09-0250 1
Topics Study Objective Introduction Study Methods Study Results Control and Prevention References 2
Study Objective   OBJECTIVE:   Perform descriptive epidemiology of Norovirus (NV) in a nursing home outbreak and examine patient risk factors in transmission of Norovirus caused gastroenteritis. 3
Introduction NOROVIRUS Basic Epidemiology Agent – Norovirus, or Norwalk-like virus, classified as calciviruses, thought to be the most common causal agents of NONBACTERIAL gastroenteritis outbreaks. Reservoir – Humans only known reservoir Transmission Modes - probably by fecal-oral route, although in hospital setting contact or airborne transmission from vomitus and fomites.  Also community food borne, waterborne and shellfish transmission  Season – common name winter vomiting disease , stomach flu, viral diarrhea Geography – worldwide and common 4
Intro Cont’d-Clinical Manifestations Incubation Period – usually 24-48 hrs, but ranges from 10-50 hours Period of Communicability- during acute stage and up to 48 hours  after diarrhea stops Characteristic Symptoms- N/V, diarrhea, abdominal pain, myalgia, h/a, malaise, low grade fever, or a combination Communicability – 48 hrs after last diarrhea, but viral shedding can occur from 7 days up to 2 weeks and infection risks unknown. Notorious Outbreak - The first recorded epidemic attributed to Norwalk virus occurred in an elementary school in Norwalk, Ohio, in 1968.  5
Complications Researchers hypothesized that certain persons might be genetically more susceptible to NLV infection and disease, in particular blood type O. If true, this hypothesis could explain why those with greater levels of preexisting antibody are more likely to experience NLV infection and disease after re-exposure to virus.      6 People who get viral gastroenteritis almost always recover completely .  HOWEVER: ,[object Object]
Infants, young children, and persons who are unable to care for themselves, such as the disabled or elderly, are at risk for dehydration from loss of fluids.
 Immune compromised persons are at risk for dehydration because they may get a more serious illness, with greater vomiting or diarrhea.
They may need to be hospitalized for treatment to correct or prevent dehydration. ,[object Object]
8
Host Risk Factors Demographics – Very Young under 5yo or very old over 65 yo Nutritional status if compromised Immune Status if compromised Other- close quarters such as cruise ships, camps, acute and long term care settings 9
Study Methods Epidemiological data and lab results collected in post-outbreak observational study  Setting 150 bed nursing home facility in eastern North Carolina.  Case status, symptom characteristics and potential risk factors identified using Medical-record review,  24-hour reports of change of condition and patient quarterly assessment.  Financial and staff related data identified through key informant interview.  De-identified data used in analysis.  10
Data entered into Excel 2007 and Powerpoint 2007 for exhibits Data entered into GOATv2.1 (general outbreak analysis tool) used by NCPH Regional Surveillance Team Six  with Epi Info v3.5.1 Data entered into PASW 17.0 for frequencies Data entered into JMP univariate analysis, correlations, exhibits 11 Methods cont’d
RESULTS:  Anoutbreak duration of 15 days with 2.2 median days illness affected 97 patients (66%) and 24 staff (15%) with symptoms of acute gastroenteritis.  71 patients met case definition, 49.6% patient-case attack rate.   Ten patients required in house oral and IV rehydration, six patients required hospital evaluation, and one patient with co-morbidities died.  A source case  was identified.  No association between food or water consumption and symptoms was identified after environmental testing of water, ice and food service.   A NV strain in the Genogroup type II was identified.   Residents were at higher risk of infection if they were physically dependent on staff care with a dependency score lower than ten {RR} of 1.22 95 %CI (range 0.60-2.47) or had an ill roommate {RR} of 1.23 95% CI (range 0.86-1.78).   12 Results- OVERVIEW
The average patient who became ill was an African American or Caucasian female with mean age of 83 years old; residents without illness were 7.5 years younger (mean age 75.5, p=0.06)  There were no significant differences in race associated with increased risk of infection (59% African American) but there was in gender.   Sixty - four patient-cases (89% of the infected cases) were female and seven patient-cases (13%) were male patient-cases at the facility. Sixty six percent (66%) of all the women in the retrospective cohort meeting case definitions were infected compared with thirty two percent (32%) of the men.   Female RR=1.20 (95% CI 1.99 -1.43, p = 0.03).    13 Results- PERSON
FACILITY FLOORPLAN Both nursing units and all six wards had patients exhibiting acute gastroenteritis (AGE) symptoms Four of the six wards also had confirmed NV lab specimens (see Figure 1 NV lab confirmed case-patient rooms indicated with red dots). 14 Results-PLACE
Time Outbreak duration of 15 days   2.2 median days illness  (range .5 -8 days) 15 Results-  Day 8 NV lab confirmed, Enhanced  Measures begun & LHD Notified Day 5 Clinical  outbreak protocol  begins Day 8 Ban on admissions & transfers begins Day 1 Index Case  Report Day 8 LHD & SHD Notified Day 13 Last New Onset
Table 1   SYMPTOMS OF CASE-PATIENTS OF A LONG-TERM–CARE FACILITY DURING A NOROVIRUS OUTBREAK FROM DECEMBER 29, 2008 TO JANUARY 13, 2009* _____________________________________________________________________________ Characteristic    CASE-Patient	                                     n/N                               (%) ________________________________________________________________________ Female	                                                                         67/126     	 (87% of cohort  )  Age 	                                                                         83 yo       	 (range 53 to 105 years)         Peak illness onset dates                                          January 6, 2009            Illness Duration                                                         15 days   	 (Dec 29’08-Jan 13,’09)                                                                                           Median duration of illness in days                                 2.2 days   	  (range 0.5- 9 days)  †Median no. Co-Morbidities		          1.8            	  (range 0-4) Symptom Diarrhea		                                          67/71   	 (94 %   of ill) Median number of stools in a 24 period                         3.5       	 (range 2-6) Median days duration of diarrhea                                    2.1      	 (range1-5)  Nausea			   			                                                                           8/71    	 (10.4% of Ill) Vomiting						                                                                          53/71   	 (68.8% of Ill) Abdominal cramps					                                                                            1/71    	 (1%      of Ill) Low Temp					  	                                                                                               31/71  	 (40.2% of Ill) Maximum Temp	                                         100.5 F Headache & Myalgia		             1/71    	 (1%      of Ill)	 16 Results- Symptoms
Risk Factor                            Symptomatic   no Symptoms          RR      CI    Range     P/Test ________________________________________________________________________ Female		 63	40          1.19	  95(1.99  -1.43)	                                                                           		     P 0.03*  Male		  8	14          0.453 	  95  (0.19 -0.96) 				   	     P 0.03*   Caucasian		30	16           1.426 	95(0.87-2.33) 										    P 0.15   Sick Roommate	 40                            24          1.23  	95(0.85-1.78) 										    P 0.24 <3 days ill		39	54            1.82  	95(1.47-2.25)                							                                                                    P<.0001*   >1 day ill		60                            54            1.18 	 95(1.07-1.31)             							                                                                     P 0.0025* Lived on M ward                         6	14             0.32	95(0.134-0.792)        									                                     P  0.0083* ADL<10score Dependency	16	10             1.217	95(0.60-2.46) 									                                     P 0.584 17 Results- Risk Factors
Preventive Measures Preventive measures: Frequently wash your hands, especially after toilet visits and changing diapers and before eating or preparing food.  Carefully wash fruits and vegetables, and steam oysters before eating them.  Thoroughly clean and disinfect contaminated surfaces immediately after an episode of illness by using a bleach-based household cleaner.  Immediately remove and wash clothing or linens that may be contaminated with virus after an episode of illness (use hot water and soap).  Flush or discard any vomitus and/or stool in the toilet and make sure that the surrounding area is kept clean.  Persons who are infected with Norovirus should not prepare food while they have symptoms and for 3 days after they recover from their illness  Use hygiene measure applicable to diseases transmitted via fecal-oral route and respiratory hygiene if vomitus prevalent due to airborne droplets 18
Control Measures Surveillance: Report to local health authority:  obligatory report of epidemics in some countries, no individual case report required.           Surveillance of Norovirus Infection in the United States CDC currently does not conduct active surveillance to monitor outbreaks of gastroenteritis caused by noroviruses. Outbreaks are reported to CDC's Viral Gastroenteritis Section, Respiratory and Gastroenteric Viruses Branch, Division of Viral Diseases, National Center for Immunization and Respiratory Diseases (NCIRD) when states send specimens for testing or sequencing, or outbreaks are reported directly by states to the electronic database (eFORS) maintained by the Foodborne Diarrheal Diseases Branch. For further details please email calicinet@cdc.gov Confirmations: Lab  stool and serum cultures- Virus may be identified in stools through RT-PCR reverse transcription polymerase chain reaction and antigen assays.  In addition, several epidemiologic criteria have been proposed for use in determining whether an outbreak of gastroenteritis is of viral origin. Kaplan's criteria for this purpose are as follows: 1) a mean (or median) illness duration of 12 to 60 hours, 2) a mean (or median) incubation period of 24 to 48 hours, 3) more than 50% of people with vomiting, and 4) no bacterial agent previously found. Although quite specific, these criteria are not very sensitive, and therefore the possibility of a viral etiology should not be discarded if the criteria are not met. Precautions: control patient, contacts and the immediate environment Isolation of cases – Enteric precautions,-No quarantine Disease specific treatment-Fluid and electrolyte replacement in severe cases.  In children aged less than five, give 10 mg elemental zinc per day for 10-14 days. Products like pedialyte and gatorade used 19
Future Directions in the USA Challenges:   In addition to fecal/oral spread, Norovirus disease can spread via droplets from vomitus (person to person transmission) . So facilities must focus on methods to limit transmission including isolation precautions (e.g., cohort sick patients in a healthcare facility) and environmental disinfection.Noroviruses are highly resistant to standard sanitation measures. They are able to survive freezing, temperatures as high as 60°C, and have even been associated with illness after being steamed in shellfish. Moreover, noroviruses can survive in up to 10 ppm chlorine, well in excess of levels routinely present in public water systems.  Epidemic measures:  Search for vehicles of transmission and source but don’t wait for lab confirmations, need to implement control measures immediately. Disaster implications:  Large-scale outbreaks could be a potential problem if water supplies or food preparation below hygiene standards. 20
21 Conclusions ,[object Object]

More Related Content

What's hot

An update on treatment of genotype 1
An update on treatment of genotype 1An update on treatment of genotype 1
An update on treatment of genotype 1usapuka
 
Clinical presentation and outcomes of HIV positive patients with diagnosis of...
Clinical presentation and outcomes of HIV positive patients with diagnosis of...Clinical presentation and outcomes of HIV positive patients with diagnosis of...
Clinical presentation and outcomes of HIV positive patients with diagnosis of...Oscar Malpartida-Tabuchi
 
A study on chronic gastritis in the east coast of Peninsular Malaysia
A study on chronic gastritis in the east coast of Peninsular Malaysia A study on chronic gastritis in the east coast of Peninsular Malaysia
A study on chronic gastritis in the east coast of Peninsular Malaysia Yeong Yeh Lee
 
A Clinical Study: Tumour Necrosis Factor Alpha as a Clinical Marker in Malari...
A Clinical Study: Tumour Necrosis Factor Alpha as a Clinical Marker in Malari...A Clinical Study: Tumour Necrosis Factor Alpha as a Clinical Marker in Malari...
A Clinical Study: Tumour Necrosis Factor Alpha as a Clinical Marker in Malari...iosrjce
 
Guidelines For The Management Hiv 2009
Guidelines For The Management Hiv 2009Guidelines For The Management Hiv 2009
Guidelines For The Management Hiv 2009usapuka
 
Chronic Hep B Update 2009%208 24 2009
Chronic Hep B Update 2009%208 24 2009Chronic Hep B Update 2009%208 24 2009
Chronic Hep B Update 2009%208 24 2009usapuka
 
Hepatitis C virus infection and type 2 diabetes mellitus in Mexican patients.
Hepatitis C virus infection and type 2 diabetes mellitus in Mexican patients. Hepatitis C virus infection and type 2 diabetes mellitus in Mexican patients.
Hepatitis C virus infection and type 2 diabetes mellitus in Mexican patients. Erwin Chiquete, MD, PhD
 
Comparative Outcomes of C difficile infected patients with NAP1 v non NAP1 st...
Comparative Outcomes of C difficile infected patients with NAP1 v non NAP1 st...Comparative Outcomes of C difficile infected patients with NAP1 v non NAP1 st...
Comparative Outcomes of C difficile infected patients with NAP1 v non NAP1 st...Benjamin (Ben) Cottongim
 
Antinuclear antibody positivity in chronic hepatitis c patients
Antinuclear antibody positivity  in chronic hepatitis c patientsAntinuclear antibody positivity  in chronic hepatitis c patients
Antinuclear antibody positivity in chronic hepatitis c patientsRashed Hassen
 
Management of Fournier’s Gangrene in a Low Resource Setting
Management of Fournier’s Gangrene in a Low Resource SettingManagement of Fournier’s Gangrene in a Low Resource Setting
Management of Fournier’s Gangrene in a Low Resource Settingasclepiuspdfs
 
Clinical and epidemiological characteristics of childhood
Clinical and epidemiological characteristics of childhoodClinical and epidemiological characteristics of childhood
Clinical and epidemiological characteristics of childhoodtloanphan
 
Effects of Coagulation Parameters On Severity Of Acute Pancreatitis In Obese ...
Effects of Coagulation Parameters On Severity Of Acute PancreatitisIn Obese ...Effects of Coagulation Parameters On Severity Of Acute PancreatitisIn Obese ...
Effects of Coagulation Parameters On Severity Of Acute Pancreatitis In Obese ...Hüseyin Akgün
 
Clinical and epidemiological characteristics of childhood vitiligo a study of...
Clinical and epidemiological characteristics of childhood vitiligo a study of...Clinical and epidemiological characteristics of childhood vitiligo a study of...
Clinical and epidemiological characteristics of childhood vitiligo a study of...tloanphan
 
Guidelines By The Surgical Infection
Guidelines By The Surgical InfectionGuidelines By The Surgical Infection
Guidelines By The Surgical Infectionusapuka
 
Alimentacion nasogastrica vs nasoyeyunal en pancreatitis aguda
Alimentacion nasogastrica vs nasoyeyunal en pancreatitis agudaAlimentacion nasogastrica vs nasoyeyunal en pancreatitis aguda
Alimentacion nasogastrica vs nasoyeyunal en pancreatitis agudaFerstman Duran
 
A study on clinical presentation and various risk factors associated with pht...
A study on clinical presentation and various risk factors associated with pht...A study on clinical presentation and various risk factors associated with pht...
A study on clinical presentation and various risk factors associated with pht...IjcmsdrJournal
 

What's hot (20)

Acute pancreatitis
Acute pancreatitisAcute pancreatitis
Acute pancreatitis
 
An update on treatment of genotype 1
An update on treatment of genotype 1An update on treatment of genotype 1
An update on treatment of genotype 1
 
Clinical presentation and outcomes of HIV positive patients with diagnosis of...
Clinical presentation and outcomes of HIV positive patients with diagnosis of...Clinical presentation and outcomes of HIV positive patients with diagnosis of...
Clinical presentation and outcomes of HIV positive patients with diagnosis of...
 
A study on chronic gastritis in the east coast of Peninsular Malaysia
A study on chronic gastritis in the east coast of Peninsular Malaysia A study on chronic gastritis in the east coast of Peninsular Malaysia
A study on chronic gastritis in the east coast of Peninsular Malaysia
 
Abdominal tuberculosis
Abdominal tuberculosisAbdominal tuberculosis
Abdominal tuberculosis
 
A Clinical Study: Tumour Necrosis Factor Alpha as a Clinical Marker in Malari...
A Clinical Study: Tumour Necrosis Factor Alpha as a Clinical Marker in Malari...A Clinical Study: Tumour Necrosis Factor Alpha as a Clinical Marker in Malari...
A Clinical Study: Tumour Necrosis Factor Alpha as a Clinical Marker in Malari...
 
Guidelines For The Management Hiv 2009
Guidelines For The Management Hiv 2009Guidelines For The Management Hiv 2009
Guidelines For The Management Hiv 2009
 
Chronic Hep B Update 2009%208 24 2009
Chronic Hep B Update 2009%208 24 2009Chronic Hep B Update 2009%208 24 2009
Chronic Hep B Update 2009%208 24 2009
 
Hepatitis C virus infection and type 2 diabetes mellitus in Mexican patients.
Hepatitis C virus infection and type 2 diabetes mellitus in Mexican patients. Hepatitis C virus infection and type 2 diabetes mellitus in Mexican patients.
Hepatitis C virus infection and type 2 diabetes mellitus in Mexican patients.
 
Comparative Outcomes of C difficile infected patients with NAP1 v non NAP1 st...
Comparative Outcomes of C difficile infected patients with NAP1 v non NAP1 st...Comparative Outcomes of C difficile infected patients with NAP1 v non NAP1 st...
Comparative Outcomes of C difficile infected patients with NAP1 v non NAP1 st...
 
Antinuclear antibody positivity in chronic hepatitis c patients
Antinuclear antibody positivity  in chronic hepatitis c patientsAntinuclear antibody positivity  in chronic hepatitis c patients
Antinuclear antibody positivity in chronic hepatitis c patients
 
Management of Fournier’s Gangrene in a Low Resource Setting
Management of Fournier’s Gangrene in a Low Resource SettingManagement of Fournier’s Gangrene in a Low Resource Setting
Management of Fournier’s Gangrene in a Low Resource Setting
 
Clinical and epidemiological characteristics of childhood
Clinical and epidemiological characteristics of childhoodClinical and epidemiological characteristics of childhood
Clinical and epidemiological characteristics of childhood
 
Effects of Coagulation Parameters On Severity Of Acute Pancreatitis In Obese ...
Effects of Coagulation Parameters On Severity Of Acute PancreatitisIn Obese ...Effects of Coagulation Parameters On Severity Of Acute PancreatitisIn Obese ...
Effects of Coagulation Parameters On Severity Of Acute Pancreatitis In Obese ...
 
Dr. Tobias Welte: Lessons learned from the CAPNETZ study
Dr. Tobias Welte: Lessons learned from the CAPNETZ studyDr. Tobias Welte: Lessons learned from the CAPNETZ study
Dr. Tobias Welte: Lessons learned from the CAPNETZ study
 
Clinical and epidemiological characteristics of childhood vitiligo a study of...
Clinical and epidemiological characteristics of childhood vitiligo a study of...Clinical and epidemiological characteristics of childhood vitiligo a study of...
Clinical and epidemiological characteristics of childhood vitiligo a study of...
 
Genital psoriasis
Genital psoriasis Genital psoriasis
Genital psoriasis
 
Guidelines By The Surgical Infection
Guidelines By The Surgical InfectionGuidelines By The Surgical Infection
Guidelines By The Surgical Infection
 
Alimentacion nasogastrica vs nasoyeyunal en pancreatitis aguda
Alimentacion nasogastrica vs nasoyeyunal en pancreatitis agudaAlimentacion nasogastrica vs nasoyeyunal en pancreatitis aguda
Alimentacion nasogastrica vs nasoyeyunal en pancreatitis aguda
 
A study on clinical presentation and various risk factors associated with pht...
A study on clinical presentation and various risk factors associated with pht...A study on clinical presentation and various risk factors associated with pht...
A study on clinical presentation and various risk factors associated with pht...
 

Viewers also liked

Gastroenteritis en adultos 2017
Gastroenteritis en adultos 2017Gastroenteritis en adultos 2017
Gastroenteritis en adultos 2017Kenny Lopez
 
Pediatric gastroenteritis 1
Pediatric gastroenteritis 1Pediatric gastroenteritis 1
Pediatric gastroenteritis 1berrick
 
Acute gastroenteritis in children AG
Acute gastroenteritis in children AGAcute gastroenteritis in children AG
Acute gastroenteritis in children AGAkshay Golwalkar
 
Gastroenteritis
GastroenteritisGastroenteritis
Gastroenteritispediatria
 
gastroenteritis
gastroenteritisgastroenteritis
gastroenteritisnoeliarod
 

Viewers also liked (6)

Gastroenteritis en adultos 2017
Gastroenteritis en adultos 2017Gastroenteritis en adultos 2017
Gastroenteritis en adultos 2017
 
Pediatric gastroenteritis 1
Pediatric gastroenteritis 1Pediatric gastroenteritis 1
Pediatric gastroenteritis 1
 
Acute gastroenteritis in children AG
Acute gastroenteritis in children AGAcute gastroenteritis in children AG
Acute gastroenteritis in children AG
 
Gastroenteritis
GastroenteritisGastroenteritis
Gastroenteritis
 
gastroenteritis
gastroenteritisgastroenteritis
gastroenteritis
 
Gastroenteritis ppt
Gastroenteritis pptGastroenteritis ppt
Gastroenteritis ppt
 

Similar to 2.1.11template For Nv Slide Show

3.10 Nv Poster Draft
3.10 Nv Poster Draft3.10 Nv Poster Draft
3.10 Nv Poster Draftgillian1007
 
Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...
Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...
Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...Simba Takuva
 
Withdrawal of anti epileptic drugs
Withdrawal of anti epileptic drugsWithdrawal of anti epileptic drugs
Withdrawal of anti epileptic drugsPramod Krishnan
 
Personalized therapy in Pediatric ALL: Allen Yeoh
Personalized therapy in Pediatric ALL: Allen YeohPersonalized therapy in Pediatric ALL: Allen Yeoh
Personalized therapy in Pediatric ALL: Allen Yeohspa718
 
Chapter 2.2 screening test
Chapter 2.2 screening testChapter 2.2 screening test
Chapter 2.2 screening testNilesh Kucha
 
Assessing the effects of prognostic factors in recovery of tuberculosis patie...
Assessing the effects of prognostic factors in recovery of tuberculosis patie...Assessing the effects of prognostic factors in recovery of tuberculosis patie...
Assessing the effects of prognostic factors in recovery of tuberculosis patie...Alexander Decker
 
Hirschsprung’s disease in adults: Clinical and therapeutic features
Hirschsprung’s disease in adults: Clinical and therapeutic featuresHirschsprung’s disease in adults: Clinical and therapeutic features
Hirschsprung’s disease in adults: Clinical and therapeutic featuresPremier Publishers
 
Lecture of epidemiology
Lecture of epidemiologyLecture of epidemiology
Lecture of epidemiologyAmany El-seoud
 
Screening and diagnostic testing
Screening and diagnostic  testingScreening and diagnostic  testing
Screening and diagnostic testingamitakashyap1
 
Outcomes of high grade thalamic gliomas in a cancer centre
Outcomes of high grade thalamic gliomas in a cancer centreOutcomes of high grade thalamic gliomas in a cancer centre
Outcomes of high grade thalamic gliomas in a cancer centreMary Ondinee Manalo Igot
 
3 prof james bently hpv vaccination 2014
3  prof james bently hpv vaccination 20143  prof james bently hpv vaccination 2014
3 prof james bently hpv vaccination 2014Tariq Mohammed
 
Pandemic H1 N1 Influenza
Pandemic H1 N1 InfluenzaPandemic H1 N1 Influenza
Pandemic H1 N1 Influenzahappyneige
 
12 Quimioterapia, 1ª - 2ª línea y mantenimiento. Cáncer de Pulmón
12 Quimioterapia, 1ª - 2ª línea y mantenimiento. Cáncer de Pulmón12 Quimioterapia, 1ª - 2ª línea y mantenimiento. Cáncer de Pulmón
12 Quimioterapia, 1ª - 2ª línea y mantenimiento. Cáncer de PulmónEffyciens Marketing Online SL.
 
1. IDSP - Overview.pptx
1. IDSP - Overview.pptx1. IDSP - Overview.pptx
1. IDSP - Overview.pptxvijinandu1
 
Cnw170 heyland nutrition risk assessment.v3 feb 19 17 revised
Cnw170 heyland nutrition risk assessment.v3 feb 19 17 revisedCnw170 heyland nutrition risk assessment.v3 feb 19 17 revised
Cnw170 heyland nutrition risk assessment.v3 feb 19 17 revisedbejo10
 
Introduction to epidemiology
Introduction to epidemiologyIntroduction to epidemiology
Introduction to epidemiologymlogaraj
 
Clinical Impact of New Data From AIDS 2018
Clinical Impact of New Data From AIDS 2018Clinical Impact of New Data From AIDS 2018
Clinical Impact of New Data From AIDS 2018hivlifeinfo
 

Similar to 2.1.11template For Nv Slide Show (20)

3.10 Nv Poster Draft
3.10 Nv Poster Draft3.10 Nv Poster Draft
3.10 Nv Poster Draft
 
Update from CROI 2018: Focus on TB and Other Opportunistic Infections
Update from CROI 2018: Focus on TB and Other Opportunistic InfectionsUpdate from CROI 2018: Focus on TB and Other Opportunistic Infections
Update from CROI 2018: Focus on TB and Other Opportunistic Infections
 
Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...
Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...
Simbarashe Takuva, AIDS 2010. Durability of first line antiretroviral therapy...
 
Withdrawal of anti epileptic drugs
Withdrawal of anti epileptic drugsWithdrawal of anti epileptic drugs
Withdrawal of anti epileptic drugs
 
Personalized therapy in Pediatric ALL: Allen Yeoh
Personalized therapy in Pediatric ALL: Allen YeohPersonalized therapy in Pediatric ALL: Allen Yeoh
Personalized therapy in Pediatric ALL: Allen Yeoh
 
Chapter 2.2 screening test
Chapter 2.2 screening testChapter 2.2 screening test
Chapter 2.2 screening test
 
chapter2-191105204556.pdf
chapter2-191105204556.pdfchapter2-191105204556.pdf
chapter2-191105204556.pdf
 
Professor Soo Downe
Professor Soo DowneProfessor Soo Downe
Professor Soo Downe
 
Assessing the effects of prognostic factors in recovery of tuberculosis patie...
Assessing the effects of prognostic factors in recovery of tuberculosis patie...Assessing the effects of prognostic factors in recovery of tuberculosis patie...
Assessing the effects of prognostic factors in recovery of tuberculosis patie...
 
Hirschsprung’s disease in adults: Clinical and therapeutic features
Hirschsprung’s disease in adults: Clinical and therapeutic featuresHirschsprung’s disease in adults: Clinical and therapeutic features
Hirschsprung’s disease in adults: Clinical and therapeutic features
 
Lecture of epidemiology
Lecture of epidemiologyLecture of epidemiology
Lecture of epidemiology
 
Screening and diagnostic testing
Screening and diagnostic  testingScreening and diagnostic  testing
Screening and diagnostic testing
 
Outcomes of high grade thalamic gliomas in a cancer centre
Outcomes of high grade thalamic gliomas in a cancer centreOutcomes of high grade thalamic gliomas in a cancer centre
Outcomes of high grade thalamic gliomas in a cancer centre
 
3 prof james bently hpv vaccination 2014
3  prof james bently hpv vaccination 20143  prof james bently hpv vaccination 2014
3 prof james bently hpv vaccination 2014
 
Pandemic H1 N1 Influenza
Pandemic H1 N1 InfluenzaPandemic H1 N1 Influenza
Pandemic H1 N1 Influenza
 
12 Quimioterapia, 1ª - 2ª línea y mantenimiento. Cáncer de Pulmón
12 Quimioterapia, 1ª - 2ª línea y mantenimiento. Cáncer de Pulmón12 Quimioterapia, 1ª - 2ª línea y mantenimiento. Cáncer de Pulmón
12 Quimioterapia, 1ª - 2ª línea y mantenimiento. Cáncer de Pulmón
 
1. IDSP - Overview.pptx
1. IDSP - Overview.pptx1. IDSP - Overview.pptx
1. IDSP - Overview.pptx
 
Cnw170 heyland nutrition risk assessment.v3 feb 19 17 revised
Cnw170 heyland nutrition risk assessment.v3 feb 19 17 revisedCnw170 heyland nutrition risk assessment.v3 feb 19 17 revised
Cnw170 heyland nutrition risk assessment.v3 feb 19 17 revised
 
Introduction to epidemiology
Introduction to epidemiologyIntroduction to epidemiology
Introduction to epidemiology
 
Clinical Impact of New Data From AIDS 2018
Clinical Impact of New Data From AIDS 2018Clinical Impact of New Data From AIDS 2018
Clinical Impact of New Data From AIDS 2018
 

2.1.11template For Nv Slide Show

  • 1. Norovirus Outbreak in a Long Term Care Facility: A Retrospective Epidemiological Study Gillian Jones MBA MPH, PIDr. Tae LeeDr. Jason Brinkley UMC-IRB # 09-0250 1
  • 2. Topics Study Objective Introduction Study Methods Study Results Control and Prevention References 2
  • 3. Study Objective   OBJECTIVE: Perform descriptive epidemiology of Norovirus (NV) in a nursing home outbreak and examine patient risk factors in transmission of Norovirus caused gastroenteritis. 3
  • 4. Introduction NOROVIRUS Basic Epidemiology Agent – Norovirus, or Norwalk-like virus, classified as calciviruses, thought to be the most common causal agents of NONBACTERIAL gastroenteritis outbreaks. Reservoir – Humans only known reservoir Transmission Modes - probably by fecal-oral route, although in hospital setting contact or airborne transmission from vomitus and fomites. Also community food borne, waterborne and shellfish transmission Season – common name winter vomiting disease , stomach flu, viral diarrhea Geography – worldwide and common 4
  • 5. Intro Cont’d-Clinical Manifestations Incubation Period – usually 24-48 hrs, but ranges from 10-50 hours Period of Communicability- during acute stage and up to 48 hours after diarrhea stops Characteristic Symptoms- N/V, diarrhea, abdominal pain, myalgia, h/a, malaise, low grade fever, or a combination Communicability – 48 hrs after last diarrhea, but viral shedding can occur from 7 days up to 2 weeks and infection risks unknown. Notorious Outbreak - The first recorded epidemic attributed to Norwalk virus occurred in an elementary school in Norwalk, Ohio, in 1968. 5
  • 6.
  • 7. Infants, young children, and persons who are unable to care for themselves, such as the disabled or elderly, are at risk for dehydration from loss of fluids.
  • 8. Immune compromised persons are at risk for dehydration because they may get a more serious illness, with greater vomiting or diarrhea.
  • 9.
  • 10. 8
  • 11. Host Risk Factors Demographics – Very Young under 5yo or very old over 65 yo Nutritional status if compromised Immune Status if compromised Other- close quarters such as cruise ships, camps, acute and long term care settings 9
  • 12. Study Methods Epidemiological data and lab results collected in post-outbreak observational study Setting 150 bed nursing home facility in eastern North Carolina. Case status, symptom characteristics and potential risk factors identified using Medical-record review, 24-hour reports of change of condition and patient quarterly assessment. Financial and staff related data identified through key informant interview. De-identified data used in analysis. 10
  • 13. Data entered into Excel 2007 and Powerpoint 2007 for exhibits Data entered into GOATv2.1 (general outbreak analysis tool) used by NCPH Regional Surveillance Team Six with Epi Info v3.5.1 Data entered into PASW 17.0 for frequencies Data entered into JMP univariate analysis, correlations, exhibits 11 Methods cont’d
  • 14. RESULTS: Anoutbreak duration of 15 days with 2.2 median days illness affected 97 patients (66%) and 24 staff (15%) with symptoms of acute gastroenteritis. 71 patients met case definition, 49.6% patient-case attack rate. Ten patients required in house oral and IV rehydration, six patients required hospital evaluation, and one patient with co-morbidities died. A source case  was identified. No association between food or water consumption and symptoms was identified after environmental testing of water, ice and food service. A NV strain in the Genogroup type II was identified. Residents were at higher risk of infection if they were physically dependent on staff care with a dependency score lower than ten {RR} of 1.22 95 %CI (range 0.60-2.47) or had an ill roommate {RR} of 1.23 95% CI (range 0.86-1.78).   12 Results- OVERVIEW
  • 15. The average patient who became ill was an African American or Caucasian female with mean age of 83 years old; residents without illness were 7.5 years younger (mean age 75.5, p=0.06) There were no significant differences in race associated with increased risk of infection (59% African American) but there was in gender. Sixty - four patient-cases (89% of the infected cases) were female and seven patient-cases (13%) were male patient-cases at the facility. Sixty six percent (66%) of all the women in the retrospective cohort meeting case definitions were infected compared with thirty two percent (32%) of the men. Female RR=1.20 (95% CI 1.99 -1.43, p = 0.03). 13 Results- PERSON
  • 16. FACILITY FLOORPLAN Both nursing units and all six wards had patients exhibiting acute gastroenteritis (AGE) symptoms Four of the six wards also had confirmed NV lab specimens (see Figure 1 NV lab confirmed case-patient rooms indicated with red dots). 14 Results-PLACE
  • 17. Time Outbreak duration of 15 days 2.2 median days illness (range .5 -8 days) 15 Results- Day 8 NV lab confirmed, Enhanced Measures begun & LHD Notified Day 5 Clinical outbreak protocol begins Day 8 Ban on admissions & transfers begins Day 1 Index Case Report Day 8 LHD & SHD Notified Day 13 Last New Onset
  • 18. Table 1 SYMPTOMS OF CASE-PATIENTS OF A LONG-TERM–CARE FACILITY DURING A NOROVIRUS OUTBREAK FROM DECEMBER 29, 2008 TO JANUARY 13, 2009* _____________________________________________________________________________ Characteristic CASE-Patient n/N (%) ________________________________________________________________________ Female 67/126 (87% of cohort ) Age 83 yo (range 53 to 105 years) Peak illness onset dates January 6, 2009 Illness Duration 15 days (Dec 29’08-Jan 13,’09) Median duration of illness in days 2.2 days (range 0.5- 9 days) †Median no. Co-Morbidities 1.8 (range 0-4) Symptom Diarrhea 67/71 (94 % of ill) Median number of stools in a 24 period 3.5 (range 2-6) Median days duration of diarrhea 2.1 (range1-5) Nausea 8/71 (10.4% of Ill) Vomiting 53/71 (68.8% of Ill) Abdominal cramps 1/71 (1% of Ill) Low Temp 31/71 (40.2% of Ill) Maximum Temp 100.5 F Headache & Myalgia 1/71 (1% of Ill) 16 Results- Symptoms
  • 19. Risk Factor Symptomatic no Symptoms RR CI Range P/Test ________________________________________________________________________ Female 63 40 1.19 95(1.99 -1.43) P 0.03* Male 8 14 0.453 95 (0.19 -0.96) P 0.03*   Caucasian 30 16 1.426 95(0.87-2.33) P 0.15   Sick Roommate 40 24 1.23 95(0.85-1.78) P 0.24 <3 days ill 39 54 1.82 95(1.47-2.25) P<.0001*   >1 day ill 60 54 1.18 95(1.07-1.31) P 0.0025* Lived on M ward 6 14 0.32 95(0.134-0.792) P 0.0083* ADL<10score Dependency 16 10 1.217 95(0.60-2.46) P 0.584 17 Results- Risk Factors
  • 20. Preventive Measures Preventive measures: Frequently wash your hands, especially after toilet visits and changing diapers and before eating or preparing food. Carefully wash fruits and vegetables, and steam oysters before eating them. Thoroughly clean and disinfect contaminated surfaces immediately after an episode of illness by using a bleach-based household cleaner. Immediately remove and wash clothing or linens that may be contaminated with virus after an episode of illness (use hot water and soap). Flush or discard any vomitus and/or stool in the toilet and make sure that the surrounding area is kept clean. Persons who are infected with Norovirus should not prepare food while they have symptoms and for 3 days after they recover from their illness Use hygiene measure applicable to diseases transmitted via fecal-oral route and respiratory hygiene if vomitus prevalent due to airborne droplets 18
  • 21. Control Measures Surveillance: Report to local health authority: obligatory report of epidemics in some countries, no individual case report required. Surveillance of Norovirus Infection in the United States CDC currently does not conduct active surveillance to monitor outbreaks of gastroenteritis caused by noroviruses. Outbreaks are reported to CDC's Viral Gastroenteritis Section, Respiratory and Gastroenteric Viruses Branch, Division of Viral Diseases, National Center for Immunization and Respiratory Diseases (NCIRD) when states send specimens for testing or sequencing, or outbreaks are reported directly by states to the electronic database (eFORS) maintained by the Foodborne Diarrheal Diseases Branch. For further details please email calicinet@cdc.gov Confirmations: Lab stool and serum cultures- Virus may be identified in stools through RT-PCR reverse transcription polymerase chain reaction and antigen assays. In addition, several epidemiologic criteria have been proposed for use in determining whether an outbreak of gastroenteritis is of viral origin. Kaplan's criteria for this purpose are as follows: 1) a mean (or median) illness duration of 12 to 60 hours, 2) a mean (or median) incubation period of 24 to 48 hours, 3) more than 50% of people with vomiting, and 4) no bacterial agent previously found. Although quite specific, these criteria are not very sensitive, and therefore the possibility of a viral etiology should not be discarded if the criteria are not met. Precautions: control patient, contacts and the immediate environment Isolation of cases – Enteric precautions,-No quarantine Disease specific treatment-Fluid and electrolyte replacement in severe cases. In children aged less than five, give 10 mg elemental zinc per day for 10-14 days. Products like pedialyte and gatorade used 19
  • 22. Future Directions in the USA Challenges: In addition to fecal/oral spread, Norovirus disease can spread via droplets from vomitus (person to person transmission) . So facilities must focus on methods to limit transmission including isolation precautions (e.g., cohort sick patients in a healthcare facility) and environmental disinfection.Noroviruses are highly resistant to standard sanitation measures. They are able to survive freezing, temperatures as high as 60°C, and have even been associated with illness after being steamed in shellfish. Moreover, noroviruses can survive in up to 10 ppm chlorine, well in excess of levels routinely present in public water systems. Epidemic measures: Search for vehicles of transmission and source but don’t wait for lab confirmations, need to implement control measures immediately. Disaster implications: Large-scale outbreaks could be a potential problem if water supplies or food preparation below hygiene standards. 20
  • 23.
  • 24. Multi disciplinary enhanced hygiene measures limited outbreak to fifteen days.
  • 25.
  • 26.
  • 28. Heijne JC, Teunis P, Morroy G, et al. Enhanced hygiene measures and norovirus transmission during an outbreak. Emerg Infect Dis. 2009;15(1):24-30.
  • 29. Norwalk-Like Viruses:' Public Health Consequences and Outbreak Management," MMWR, June 01, 2001 / 50(RR09);1-18
  • 30. Marx A, Shay DK, Noel JS, et al. Outbreak of acute gastroenteritis in a geriatric long-term-care facility: combined application of epidemiological and molecular diagnostic methods. Infect Cont Hosp Epidemiol 1999;20:306--11.
  • 31. Jiang X, Turf E, Hu J, et al. Outbreaks of gastroenteritis in elderly nursing homes and retirement facilities associated with human caliciviruses. J Med Virol 1996;50:335--41.
  • 32.